---
figid: PMC7558103__pharmaceuticals-13-00247-g001
figtitle: The nicotinamide adenine dinucleotide (NAD) metabolism
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC7558103
filename: pharmaceuticals-13-00247-g001.jpg
figlink: pmc/articles/PMC7558103/figure/pharmaceuticals-13-00247-f001/
number: F1
caption: Regulation of the nicotinamide adenine dinucleotide (NAD) metabolism. The
  figure shows the main synthesis pathways of NAD including the de novo synthesis
  via the kynurenine pathway or from nicotinic acid and the salvage pathways.
papertitle: Clinical Evidence for Targeting NAD Therapeutically.
reftext: Dina Radenkovic, et al. Pharmaceuticals (Basel). 2020 Sep;13(9):247.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9109919
figid_alias: PMC7558103__F1
figtype: Figure
redirect_from: /figures/PMC7558103__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7558103__pharmaceuticals-13-00247-g001.html
  '@type': Dataset
  description: Regulation of the nicotinamide adenine dinucleotide (NAD) metabolism.
    The figure shows the main synthesis pathways of NAD including the de novo synthesis
    via the kynurenine pathway or from nicotinic acid and the salvage pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NAPRT
  - NMNAT1
  - NMNAT3
  - NMNAT2
  - NAMPT
  - STAC3
  - Naprt
  - Nmnat1
  - Nmnat3
  - Nmnat2
  - Nampt
  - naprt
  - nmnat1
  - nmnat3
  - nmnat2
  - Nicotinic Acid
  - Vitamin B
  - Tryptophan
  - Mononucleotide
  - Adenine Dinucleotide
  - NADS
  - NAD
  - NADH
  - Nicotinamide
  - NMN
  - NAMPT
  - NAM
---
